Loading...
Radiolabeled Cetuximab Conjugates for EGFR Targeted Cancer Diagnostics and Therapy (†)
The epidermal growth factor receptor (EGFR) has evolved over years into a main molecular target for the treatment of different cancer entities. In this regard, the anti-EGFR antibody cetuximab has been approved alone or in combination with: (a) chemotherapy for treatment of colorectal and head and n...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3978494/ https://ncbi.nlm.nih.gov/pubmed/24603603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph7030311 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|